文献速递呼吸衰竭与机械通气

从不吸烟的哮喘患者持续呼气气流阻塞中未被怀疑的肺气肿的进一步研究

Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
PubMed 文献 · Chest · 2017-11-29
一句话结论从不吸烟的重度哮喘患者持续呼气气流阻塞可能源于未被怀疑的显微镜下轻度小叶中央型肺气肿,导致肺弹性回缩力丧失。

该研究对25例从不吸烟的慢性哮喘患者(年龄55±15岁,12例女性)进行了5至22年的前瞻性研究,这些患者存在持续中重度呼气阻塞。在吸入270 μg硫酸沙丁胺醇后,FVC为3.1±1.0 L(预计值83%±13%),FEV1为1.8±0.6 L(59%±11%),FEV1/FVC为59%±10%,DLCO/VA为4.8±1.1 mL/min/mm Hg/L(120%±26%)。所有25例患者均有静态肺弹性回缩压丧失,CT仅检测到无或轻度肺气肿。在4例已报告的尸检肺和1例未报告的移植肺中,显微镜下发现上、中肺野未被怀疑的轻度弥漫性小叶中央型肺气肿。作者认为,显微镜下轻度小叶中央型肺气肿是肺弹性回缩力丧失的前哨原因,对从不吸烟哮喘患者的呼气气流阻塞有显著贡献。

要点

  • 从不吸烟的慢性哮喘患者尽管CT仅显示无或轻度肺气肿,尸检/移植肺显微镜下可见上、中肺野轻度弥漫性小叶中央型肺气肿。
  • 所有25例哮喘患者均存在静态肺弹性回缩压丧失,且与内在气道传导率下降共同限制呼气气流。
  • 吸入270 μg硫酸沙丁胺醇后FEV1为1.8±0.6 L(预计值59%±11%),FEV1/FVC为59%±10%,DLCO/VA为4.8±1.1 mL/min/mm Hg/L(预计值120%±26%)。
  • 8例患者在哮喘缓解期,静态肺弹性回缩压计算的内在气道传导率和努力非依赖性肺容积下的最大呼气气流均增加。
  • 作者认为,显微镜下轻度小叶中央型肺气肿是肺弹性回缩力丧失的前哨原因,对从不吸烟哮喘患者的呼气气流阻塞有显著贡献。

适用人群与场景

  • 从不吸烟的慢性哮喘患者,年龄55±15岁(12例女性),存在持续中重度呼气阻塞,前瞻性研究5至22年。

诊断标准与关键阈值

  • 哮喘诊断及分型:稳定期哮喘,具有不同2型表型。
  • 呼气气流阻塞:持续中重度呼气阻塞,吸入270 μg硫酸沙丁胺醇后FEV1/FVC为59%±10%。

处置流程与药物剂量

  • 所有患者吸入270 μg硫酸沙丁胺醇硫酸盐气雾剂(定量吸入器加储雾罐)后行肺功能等检测。

研究设计与关键结果

  • 研究类型:前瞻性研究,样本量25例(12例女性),年龄55±15岁,随访5至22年。
  • 干预:吸入270 μg硫酸沙丁胺醇后测量肺功能、呼出气一氧化氮、脉冲振荡、肺弹性回缩力及高分辨率薄层(1 mm)CT全吸气相体素定量。
  • 主要终点结果:FVC 3.1±1.0 L(预计值83%±13%),FEV1 1.8±0.6 L(预计值59%±11%),FEV1/FVC 59%±10%,DLCO/VA 4.8±1.1 mL/min/mm Hg/L(预计值120%±26%)。
  • 所有25例患者均有静态肺弹性回缩压丧失,且与内在气道传导率下降共同限制呼气气流。
  • CT检测:无或轻度肺气肿。
  • 4例已报告尸检肺和1例未报告移植肺显微镜下均显示上、中肺野未被怀疑的轻度弥漫性小叶中央型肺气肿,并伴有哮喘相关气道重塑。
  • 8例患者在哮喘缓解期,静态肺弹性回缩压计算的内在气道传导率和努力非依赖性肺容积下的最大呼气气流均增加。

证据类型、等级与局限

  • 证据类型:前瞻性研究(病例系列)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对于从不吸烟的哮喘患者,即使CT显示无或轻度肺气肿且DLCO正常,若存在持续呼气气流阻塞,应考虑到显微镜下轻度小叶中央型肺气肿导致肺弹性回缩力丧失的可能。

指南或共识出处

  • 协议号20070934和研究号1090472,Western Institutional Review Board,奥林匹亚,华盛顿州;ClinicalTrials.gov;注册号NCT00576069;网址:www.clinicaltrials.gov。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Previously, we and other investigators have described reversible loss of lung elastic recoil in patients with acute and persistent, moderate-to-severe, chronic, treated asthma who never smoked, and its adverse effect on maximal expiratory airflow. In four consecutive autopsies, we reported the pathophysiologic mechanism(s) has been unsuspected mild, diffuse, middle and upper lobe centrilobular emphysema.

METHODS: We performed prospective studies (5 to 22 years) in 25 patients (12 female) with chronic asthma, age 55 ± 15 years, who never smoked, with persistent moderate-to-severe expiratory obstruction. Studies included measuring blood eosinophils, IgE, total exhaled nitric oxide (NO), central airway NO flux, peripheral airway/alveolar NO concentration, impulse oscillometry, heliox curves, lung elastic recoil, and high-resolution thin-section (1 mm) lung CT imaging at full inspiration with voxel quantification.

RESULTS: In 25 patients with stable asthma with varying type 2 phenotype, after 270 μg of aerosolized albuterol sulfate had been administered with a metered dose inhaler with space chamber, FVC was 3.1 ± 1.0 L (83% ± 13% predicted) (mean ± SD), FEV1 was 1.8 ± 0.6 L (59% ± 11%), the FEV1/FVC ratio was 59% ± 10%, and the ratio of single-breath diffusing capacity of the lung for carbon monoxide to alveolar volume was 4.8 ± 1.1 mL/min/mm Hg/L (120% ± 26%). All 25 patients with asthma had loss of static lung elastic recoil pressure, which contributed equally to decreased intrinsic airway conductance in limiting expiratory airflow. Lung CT scanning detected none or mild emphysema. In all four autopsied asthmatic lungs previously reported and one unreported explanted lung, microscopy revealed unsuspected mild, diffuse centrilobular emphysema in the upper and middle lung fields, and asthma-related remodeling in airways. In eight cases, during asthma remission, there were increases in measured static lung elastic recoil pressure-calculated intrinsic airway conductance, and measured maximal expiratory airflow at effort-independent lung volumes.

CONCLUSIONS: As documented now in five cases, unsuspected microscopic mild centrilobular emphysema is the sentinel cause of loss of lung elastic recoil. This contributes significantly to expiratory airflow obstruction in never-smoking patients with asthma, with normal diffusing capacity and near-normal lung CT scan results.

TRIAL REGISTRY: Protocol No. 20070934 and Study No. 1090472, Western Institutional Review Board, Olympia, WA; ClinicalTrials.gov; No. NCT00576069; URL: www.clinicaltrials.gov.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Gelb AF, Yamamoto A, Verbeken EK, et al. Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction. Chest. 2017. PMID: 29197547. doi:10.1016/j.chest.2017.11.016

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。